GLAXF Stock: GSK plc Stock Price, Analysis & Insights
Get live GLAXF stock price $25.12, comprehensive GSK plc stock analysis, charts, news, and expert forecast. Real-time GLAXF stock data and investment insights.
Loading chart data...
GSK plc (GLAXF) Overview
GSK plc (GLAXF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, GLAXF trades at $25.12 with a market capitalization of 100.73B . Over the past 52 weeks, GLAXF has traded between $17.15 and $31.48 , with the current price positioned at approximately 56% of this range . The stock currently tr...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 100.73B
- Current price: $25.12
- 52-week range: $17.15 - $31.48
- P/E ratio: 13.22
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
GSK plc, a global healthcare and pharmaceutical leader with roots tracing back to 1715, is headquartered in Brentford, United Kingdom. Operating extensively across the UK, United States, and other international markets, its activities span the entire...
Company Information
- CEO
- Luke Victor Miels
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 68629
Contact Information
- Website
- https://www.gsk.com
- Address
- 980 Great West Road
- Country
- GB
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 100.7 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 13.2)
✓ Lower volatility stock (Beta: 0.29) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for GSK plc shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for GSK plc
- ⚠Investors should consider how GSK plc fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
100.73B
P/E Ratio (TTM)
13.22
Beta
0.29
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare GLAXF with peer companies:
- Price
- $46.74
- Market cap
- 76.91B
- Price
- $23.32
- Market cap
- 76.76B
- Price
- $17.91
- Market cap
- 69.35B
- Price
- $15.00
- Market cap
- 27.29B
- Price
- $15.42
- Market cap
- 28.06B
- Price
- $158.20
- Market cap
- 68.78B
- Price
- $31.35
- Market cap
- 68.15B
- Price
- $31.71
- Market cap
- 33.44B
- Price
- $86.67
- Market cap
- 104.19B
- Price
- $54.23
- Market cap
- 79.24B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.